Urstadt Biddle Properties Series F Cumulative Redeemable Preferred Stock Ex-Dividend Reminder

On 7/16/14, Urstadt Biddle Properties Inc's 7.125% Series F Cumulative Redeemable Preferred Stock (UBP.PRF) will trade ex-dividend, for its quarterly dividend of $0.4453, payable on 7/31/14. As a percentage of UBP.PRF's recent share price of $25.85, this dividend works out to approximately 1.72%, so look for shares of UBP.PRF to trade 1.72% lower — all else being equal — when UBP.PRF shares open for trading on 7/16/14. On an annualized basis, the current yield is approximately 6.93%, which compares to an average yield of 6.82% in the "Real Estate" preferred stock category, according to Preferred Stock Channel.

START SLIDESHOW:
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »

As of last close, UBP.PRF was trading at a 2.80% premium to its liquidation preference amount, versus the average premium of 1.59% in the "Real Estate" category. The chart below shows the one year performance of UBP.PRF shares, versus UBP:

Performance Comparison Chart

Below is a dividend history chart for UBP.PRF, showing historical dividends prior to the most recent $0.4453 on Urstadt Biddle Properties Inc's 7.125% Series F Cumulative Redeemable Preferred Stock:

UBP.PRF+Dividend+History+Chart

In Monday trading, Urstadt Biddle Properties Inc's 7.125% Series F Cumulative Redeemable Preferred Stock ( UBP.PRF) is currently up about 0.6% on the day, while the common shares ( UBP) are up about 1.1%.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says